Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Empagliflozin

Brand: Jardiance®
NICE TA: 336
Indication: In combination therapy for treating type 2 diabetes (NICE TA336)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Empagliflozin is recommended as a treatment for type 2 diabetes when taken with metformin, only if :
•sulfonylurea cannot be taken or
•is at significant risk of hypoglycaemia or its consequences.
If a person needs to take 3 antidiabetic drugs, empagliflozin is recommended as a treatment for type 2 diabetes when taken with either metformin and a sulfonylurea, or with metformin and a thiazolidinedione.
Empagliflozin is also recommended as a treatment for type 2 diabetes when taken with insulin, with or without other antidiabetic drugs.
The LMMG recommends empagliflozin as a 1st line ““gliflozin””.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green

Green